GlassScriptPhysician profile
Olivia Nicastro
NPI 1285966010
$1,237.55
in general payments reported to CMS, 2019-2025
10 companies · $169 in 2025
The $169 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $206 · 2022: $114 · 2023: $235 · 2024: $513 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $917.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $917.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| La Jolla Pharmaceutical Company | $247.13 | 2022-2024 | Giapreza |
| Edwards Lifesciences Corporation | $162.22 | 2021 | |
| Gilead Sciences, INC. | $150.26 | 2021-2023 | Veklury |
| Boston Scientific Corporation | $140.00 | 2025 | Watchman Flx |
| Ceribell, INC. | $139.16 | 2024 | Pocket Eeg Device |
| Shionogi INC | $123.65 | 2024 | Fetroja |
| Csl Behring | $117.20 | 2024 | Kcentra |
| Abbvie INC. | $109.92 | 2023 | |
| Abiomed | $29.26 | 2025 | |
| Janssen Pharmaceuticals, INC | $18.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olivia Nicastro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.